Results 201 to 210 of about 434,771 (384)
The Protective Action of Dysentery Bacteriophage in Experimental Infections in Mice [PDF]
Harry E. Morton, Frank B. Engley
openalex +1 more source
Bismuth–Selenopeptides Combine Potent Bioactivity with Exceptional Kinetic Inertness
A major obstacle for bismuth peptides and proteins, in which Bi(III) is coordinated by three cysteine residues, is their kinetic lability when challenged with strong metal chelators. By simply replacing cysteines with selenocysteines, we significantly increased kinetic stability, extending the lifetime to several days.
Pritha Ghosh +7 more
wiley +2 more sources
Engineered RNA Devices for In Vivo Targeted Therapeutics via Advanced Delivery Systems
Schematic illustration of engineered RNA devices for in vivo targeted therapeutics via advanced delivery systems. ABSTRACT Engineered RNA devices can identify disease‐specific markers and precisely regulate gene expression, which is of great significance to the development of precision medicine.
Wei Luo +6 more
wiley +1 more source
A reversible particle nanoswitch sensor enables continuous protein monitoring by forming transient sandwich complexes in the presence of analyte molecules. Site‐specific conjugations ensure optimal antibody fragment orientation. Demonstrated for lactoferrin, the sensor achieves picomolar sensitivity with ∼12 min time delay and continuous measurements ...
Claire M. S. Michielsen +9 more
wiley +2 more sources
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
Aleksandra Petrović Fabijan +12 more
semanticscholar +1 more source
Large language models are transforming microbiome research by enabling advanced sequence profiling, functional prediction, and association mining across complex datasets. They automate microbial classification and disease‐state recognition, improving cross‐study integration and clinical diagnostics.
Jieqi Xing +4 more
wiley +1 more source
The Recovery of Bacteriophage from Filtrates Derived from Heated Spore-Suspensions [PDF]
Philip B. Cowles
openalex +1 more source
Peptide/Antibody–Drug Conjugates for Therapeutic Applications in Inflammatory Disease
Peptide/antibody–drug conjugates (PADCs) combine ligand specificity and cleavable linkers to deliver drugs precisely to disease sites with minimal toxicity. While current approvals focus on oncology, this review examines their untapped potential in inflammatory diseases, detailing mechanisms of targeted delivery and highlighting advances that position ...
Yeongji Jang +5 more
wiley +1 more source

